(Q72710432)

English

In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2

scientific article published on 01 November 1994

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

title

In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2 (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Kalebic T

1

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

Tsokos M

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

Helman LJ

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

publication date

1 November 1994

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

volume

54

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

issue

21

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

page(s)

5531-5534

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 October 2019

Identifiers

PubMed ID

7923191

1 reference

stated in

Europe PubMed Central

PubMed ID

7923191

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7923191%20AND%20SRC:MED&resulttype=core&format=json

(Q72710432)

In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)